Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04465318 · ClinicalTrials.gov registry record · NA
Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT04465318: Completed NA study, sponsored by NYU Langone Health.
NCT04465318 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04465318, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
The study team proposes a two-arm pilot study randomizing participants with COPD who smoke combustible cigarettes (CC) to counseling + NRT (standard of care) or counseling + e-cigarettes.
Primary Outcome
Smoking reduction will be measured by a self-report.
Interventions
- OTHER E-cigarette (EC)
- OTHER Nicotine Replacement Therapy (NRT)
- BEHAVIORAL Smoking Harm Reduction Counseling Sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2023-03-09 |
| Phase | NA |
What the finished NCT04465318 record still lists
NCT04465318 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which E-cigarette (EC) is the first listed.
NCT04465318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04465318 about?
NCT04465318 is a clinical study titled "Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD". The study team proposes a two-arm pilot study randomizing participants with COPD who smoke combustible cigarettes (CC) to counseling + NRT (standard of care) or counseling + e-cigarettes.
What is the current status of trial NCT04465318?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2020-11-09. Estimated completion is 2023-03-09.
What interventions are being tested in trial NCT04465318?
The interventions under investigation include: E-cigarette (EC) (OTHER), Nicotine Replacement Therapy (NRT) (OTHER), Smoking Harm Reduction Counseling Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT04465318?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04465318's enrollment target sits among peer trials
146 704th of 2000 higher than 1,296 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI